Avalo Therapeutics Inc (AVTX)
14.98
+0.78
(+5.49%)
USD |
NASDAQ |
Apr 25, 16:00
15.30
+0.32
(+2.14%)
After-Hours: 20:00
Avalo Therapeutics Revenue (TTM): 1.925M for Dec. 31, 2023
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | 1.925M |
| September 30, 2023 | 2.25M |
| June 30, 2023 | 16.96M |
| March 31, 2023 | 17.35M |
| December 31, 2022 | 18.05M |
| September 30, 2022 | 17.37M |
| June 30, 2022 | 3.775M |
| March 31, 2022 | 6.097M |
| December 31, 2021 | 5.397M |
| September 30, 2021 | 6.675M |
| June 30, 2021 | 6.436M |
| March 31, 2021 | 4.419M |
| December 31, 2020 | 6.70M |
| September 30, 2020 | 5.784M |
| Date | Value |
|---|---|
| June 30, 2020 | 6.874M |
| March 31, 2020 | 6.928M |
| December 31, 2019 | 6.750M |
| September 30, 2019 | -0.1448M |
| June 30, 2019 | 1.729M |
| March 31, 2019 | 5.122M |
| December 31, 2018 | 7.028M |
| September 30, 2018 | 15.58M |
| June 30, 2018 | 36.54M |
| March 31, 2018 | 31.91M |
| December 31, 2017 | 27.81M |
| September 30, 2017 | 25.76M |
| June 30, 2017 | 1.044M |
| March 31, 2017 | 1.537M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
-0.1448M
Minimum
Sep 2019
18.05M
Maximum
Dec 2022
7.439M
Average
6.436M
Median
Jun 2021
Revenue (TTM) Benchmarks
| Imunon Inc | -- |
| iBio Inc | -- |
| Kodiak Sciences Inc | -- |
| Petros Pharmaceuticals Inc | 5.822M |
| Ocugen Inc | -- |